Common use of Issuance of Commitment Shares Clause in Contracts

Issuance of Commitment Shares. The Company shall have issued the Commitment Shares to an account designated by the Investor, in accordance with Section 11.04, all of which Commitment Shares shall be fully earned and non-refundable, regardless of whether any Advance Notices are made or settled hereunder or any subsequent termination of this Agreement.

Appears in 15 contracts

Sources: Standby Equity Purchase Agreement (Scinai Immunotherapeutics Ltd.), Standby Equity Purchase Agreement (Icon Energy Corp), Stock Purchase Agreement (Yorkville Acquisition Corp.)

Issuance of Commitment Shares. The Company shall have issued the Commitment Shares to an account designated by the Investor, in accordance with Section 11.0412.04, all of which Commitment Shares shall be fully earned and non-refundable, regardless of whether any Advance Notices are made or settled hereunder or any subsequent termination of this Agreement.

Appears in 15 contracts

Sources: Equity Subscription Agreement (BioSig Technologies, Inc.), Standby Equity Purchase Agreement (Rail Vision Ltd.), Standby Equity Purchase Agreement (Envirotech Vehicles, Inc.)

Issuance of Commitment Shares. The Company shall have paid the Commitment Fee or issued the Commitment Shares to an account designated by the InvestorInvestor on or prior to the Effective Date, in accordance with Section 11.0412.04, all of which Commitment Shares Fee shall be fully earned and non-refundablerefundable on the Effective Date, regardless of whether any Advance Notices are made or settled hereunder or any subsequent termination of this Agreement.

Appears in 5 contracts

Sources: Standby Equity Purchase Agreement (Lytus Technologies Holdings PTV. Ltd.), Standby Equity Purchase Agreement (ConnectM Technology Solutions, Inc.), Standby Equity Purchase Agreement (Atlantic Coastal Acquisition Corp. II)

Issuance of Commitment Shares. The Company shall have paid the Commitment Fee or issued the Commitment Shares to an account designated by the InvestorInvestor on or prior to the Effective Date, in accordance with Section 11.0412.04, all of which Commitment Shares Fee shall be fully earned and non-refundable, regardless of whether any Advance Notices are made or settled hereunder or any subsequent termination of this Agreement.

Appears in 4 contracts

Sources: Standby Equity Purchase Agreement (Prairie Operating Co.), Standby Equity Purchase Agreement (Soluna Holdings, Inc), Standby Equity Purchase Agreement (Celularity Inc)

Issuance of Commitment Shares. The Company shall have issued the Commitment Shares to an account designated by the InvestorInvestor on or prior to the date hereof, in accordance with Section 11.0412.04, all of which Commitment Shares shall be fully earned and non-refundable, regardless of whether any Advance Notices are made or settled hereunder or any subsequent termination of this Agreement.

Appears in 3 contracts

Sources: Pre Paid Advance Agreement (Mainz Biomed N.V.), Reciprocal Standby Equity Purchase Agreement (SMX (Security Matters) Public LTD Co), Reciprocal Standby Equity Purchase Agreement (Lionheart III Corp)

Issuance of Commitment Shares. The Company shall have issued the Commitment Shares to an account designated by the Investor, in accordance with Section 11.0412.04, all of which Commitment Shares Shares, if issued, shall be fully earned as of the date hereof and non-refundable, regardless of whether any Advance Notices are made or settled hereunder or any subsequent termination of this Agreement.

Appears in 2 contracts

Sources: Standby Equity Purchase Agreement (Innventure, Inc.), Standby Equity Purchase Agreement (Learn CW Investment Corp)

Issuance of Commitment Shares. The Company shall have issued the Commitment Shares to an account designated by the Investor, in accordance with Section 11.04‎Section 12.04, all of which Commitment Shares shall be fully earned and non-refundable, regardless of whether any Advance Notices are made or settled hereunder or any subsequent termination of this Agreement.

Appears in 2 contracts

Sources: Standby Equity Purchase Agreement (NeuroSense Therapeutics Ltd.), Standby Equity Purchase Agreement (Galmed Pharmaceuticals Ltd.)

Issuance of Commitment Shares. The Company shall have issued the Commitment Shares to an account designated by the Investor, in accordance with Section 11.0412.04, all of which Commitment Shares Shares, shall be fully earned and non-refundable, regardless of whether any Advance Notices are made or settled hereunder or any subsequent termination of this Agreement.

Appears in 2 contracts

Sources: Standby Equity Purchase Agreement (LeddarTech Holdings Inc.), Standby Equity Purchase Agreement (LeddarTech Holdings Inc.)

Issuance of Commitment Shares. The Company shall have issued the Commitment Shares to an account designated by the Investor, Investor in accordance with Section 11.0412.04, all of which Commitment Shares shall be fully earned and non-refundable, regardless of whether any Advance Notices are made or settled hereunder or any subsequent termination of this Agreement.

Appears in 1 contract

Sources: Standby Equity Purchase Agreement (SaverOne 2014 Ltd.)

Issuance of Commitment Shares. The Company shall have issued the Commitment Shares to an account designated by the Investor, in accordance with Section 11.0412.05, all of which Commitment Shares shall be fully earned and non-refundable, regardless of whether any Advance Notices are made or settled hereunder or any subsequent termination of this Agreement.

Appears in 1 contract

Sources: Standby Equity Purchase Agreement (Lakeshore Acquisition II Corp.)

Issuance of Commitment Shares. The Company shall have issued the Commitment Shares to an account designated by the Investor, Investor in accordance with Section 11.0412.04, all of which Commitment Shares Fee shall be fully earned and non-refundable, regardless of whether any Advance Notices are made or settled hereunder or any subsequent termination of this Agreement.

Appears in 1 contract

Sources: Standby Equity Purchase Agreement (Coeptis Therapeutics Holdings, Inc.)